Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Nobumasa Okumura"'
Autor:
Ryuta Uraki, Maki Kiso, Kiyoko Iwatsuki-Horimoto, Seiya Yamayoshi, Mutsumi Ito, Shiho Chiba, Yuko Sakai-Tagawa, Masaki Imai, Yukie Kashima, Michiko Koga, Noriko Fuwa, Nobumasa Okumura, Masayuki Hojo, Noriko Iwamoto, Hideaki Kato, Hideaki Nakajima, Norio Ohmagari, Hiroshi Yotsuyanagi, Yutaka Suzuki, Yoshihiro Kawaoka
Publikováno v:
Cell Reports, Vol 42, Iss 12, Pp 113580- (2023)
Summary: EG.5.1 is a subvariant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron XBB variant that is rapidly increasing in prevalence worldwide. However, the pathogenicity, transmissibility, and immune evasion properties of
Externí odkaz:
https://doaj.org/article/3359de53c5544266aee6bf7bded1cffe
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Methicillin-susceptible Staphylococcus aureus (MSSA) is the most common causative microorganism of pyogenic vertebral osteomyelitis (PVO). Although oral antimicrobial therapy with first-generation cephalosporins can treat MSSA inf
Externí odkaz:
https://doaj.org/article/164bc2827cb9419583e4fcdf4b1e65d4
Publikováno v:
International Journal of Infectious Diseases, Vol 134, Iss , Pp 290-291 (2023)
Externí odkaz:
https://doaj.org/article/8ff6e88d194c4690845b0abdb4165ea8
Autor:
Noriko Tomita, Junko Terada-Hirashima, Yukari Uemura, Yosuke Shimizu, Haruka Iwasaki, Rina Yano, Tetsuya Suzuki, Sho Saito, Nobumasa Okumura, Wataru Sugiura, Norio Ohmagari, Mugen Ujiie
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
Mpox is an acute exanthematous disease caused by the monkeypox virus. Since May 2022, it has spread as a community-acquired infection, mainly in Europe and the United States, and urgent measures to prevent this infection were also required in Japan.
Externí odkaz:
https://doaj.org/article/e3e544fff4fa4f90941f5e86a84fb157
Autor:
Rina Yano, Junko Terada-Hirashima, Yukari Uemura, Noriko Tomita, Yosuke Shimizu, Haruka Iwasaki, Nobumasa Okumura, Tetsuya Suzuki, Sho Saito, Mugen Ujiie, Wataru Sugiura, Norio Ohmagari
Publikováno v:
JMIR Research Protocols, Vol 12, p e46955 (2023)
BackgroundIn May 2022, a case of monkeypox (currently known as “mpox”) with no history of overseas travel was reported in the United Kingdom, followed by reports of infections reported in Europe, the United States, and other countries worldwide.
Externí odkaz:
https://doaj.org/article/43f820ed932a4fe18ea22f8080ac0a3f
Autor:
Kenichiro Takahashi, Masahiro Ishikane, Mugen Ujiie, Noriko Iwamoto, Nobumasa Okumura, Testsuro Sato, Maki Nagashima, Ataru Moriya, Michiyo Suzuki, Masayuki Hojo, Takayuki Kanno, Shinji Saito, Sho Miyamoto, Akira Ainai, Minoru Tobiume, Takeshi Arashiro, Tsuguto Fujimoto, Tomoya Saito, Masaya Yamato, Tadaki Suzuki, Norio Ohmagari
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 5, Pp 998-1001 (2022)
To determine virus shedding duration, we examined clinical samples collected from the upper respiratory tracts of persons infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in Japan during November 29–December 18, 2021. V
Externí odkaz:
https://doaj.org/article/879694f6cdbc407b9b9207531ee755ad
Autor:
Noriko Tomita, Eriko Morino, Junko Terada-Hirashima, Yukari Uemura, Yosuke Shimizu, Sho Saito, Tetsuya Suzuki, Nobumasa Okumura, Haruka Iwasaki, Hideki Ebihara, Masayuki Shimojima, Wataru Sugiura, Norio Ohmagari, Mugen Ujiie
Publikováno v:
Life, Vol 13, Iss 3, p 787 (2023)
Monkeypox (mpox) is an acute exanthematous disease caused by the monkeypox virus (MPXV). Since May 2022, patients with mpox have been reported worldwide, mainly in Europe and the Americas. In Japan, LC16”KMB,” which is a smallpox vaccine derived
Externí odkaz:
https://doaj.org/article/bcc255c9687e42db8cf0aa91b74546ff
Autor:
Nobumasa Okumura, Takashi Watanabe, Satoshi Teranishi, Daisuke Suzuki, Takahiko Hashimoto, Kosuke Takahashi, Toru Hara
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-5 (2021)
Abstract Background Enterococcus casseliflavus is rarely isolated from human specimens. To the best of our knowledge, there are no reports on its detailed treatment course and prognosis. Here, we present the first known case of E. casseliflavus endoc
Externí odkaz:
https://doaj.org/article/a7155cdb5faf4334b018d89796384513
Autor:
Makoto Inada, Sho Saito, Shinya Tsuzuki, Nobumasa Okumura, Lubna Sato, Kohei Kamegai, Mio Sanada, Mika Komatsubara, Masayuki Shimojima, Hideki Ebihara, Fumi Kasuya, Mami Nagashima, Kenji Sadamasu, Kei Yamamoto, Mugen Ujiie, Shinichiro Morioka, Norio Ohmagari
Publikováno v:
Journal of Infection and Chemotherapy. 29:418-421
Publikováno v:
Open Forum Infectious Diseases. 9
Background Methicillin-susceptible Staphylococcus aureus (MSSA) is the most common causative microorganism of pyogenic vertebral osteomyelitis (VO). Oral antimicrobial therapy with first-generation cephalosporins can treat MSSA infection, but data on